Antiviral injection addressing CMV and HSV infections had US market sales of nearly $15 million in the last 12 months
The 38% adjusted EBITDA margin of base business has been supported by robust growth in the CDMO segment
The decision marks a significant expansion for Pfizer’s once-weekly injectable therapy
The facility combines advanced diagnostics, bone marrow transplant evaluation, prenatal awareness, and multidisciplinary support services
The initiative by DKMS Foundation India is for below 12 years children suffering from transfusion-dependent thalassemia
Pharma and biotech infrastructure firm targets 25–30% growth as Middle East and Africa emerge as key expansion markets
The submission is backed by positive results from the Phase 3 AFFIRM study
The approval was driven by data from the Phase III TULIP-SC trial
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
